ADDED
Intersegment eliminations, unrealized mark-to-market gains/losses on derivatives and investment in equity securities of Saudi Arabian Mining Company ( Ma aden ), debt expenses and the results of the China and India distribution businesses and Mosaic Biosciences are included within Corporate, Eliminations and Other.
The following charts show the respective contributions to 2025 sales volumes, net sales and gross margin for each of our business segments in effect at December 31, 2025: We account for approximately 10% of estimated global annual phosphate production.
We account for approximately 34% of estimated North American annual potash production.
In addition to five phosphate rock mines and four chemical plants in Brazil, this segment consists of sales offices, crop nutrient blending and bagging facilities, port terminals and warehouses in Brazil and Paraguay.
We account for approximately 73% of estimated annual production of concentrated phosphate crop nutrients in Brazil.
Business Developments During 2025 In October 2025, we completed the sale of our idled Patos de Minas phosphate mining unit in Brazil for $111 million, with $51 million paid at closing and the balance of the purchase price to be paid in installments over the next four years.
In November 2025, we completed the sale of our interest in the Taquari potash mine in Brazil for proceeds of up to $27 million, with $12 million received at closing.
We recorded an impairment loss of approximately $66 million related to the sale.
In November 2025, we completed a $900 million public bond offering, consisting of $500 million aggregate principal amount of 4.350% senior notes due 2029 and $400 million aggregate principal amount of 4.600% senior notes due 2030.
In December 2025, we entered into an agreement to sell our Carlsbad, New Mexico potash mine for approximately $30 million.
REMOVED
Intersegment eliminations, unrealized mark-to-market gains/losses on derivatives, debt expenses, and the results of the China and India distribution businesses are included within Corporate, Eliminations and Other.
The following charts show the respective contributions to 2024 sales volumes, net sales and gross margin for each of our business segments in effect at December 31, 2024: We account for approximately 11% of estimated global annual phosphate production.
We account for approximately 35% of estimated North American annual potash production.
In addition to five phosphate rock mines, four chemical plants and a potash mine in Brazil, this segment consists of sales offices, crop nutrient blending and bagging facilities, port terminals and warehouses in Brazil and Paraguay.
We account for approximately 70 to 80% of estimated annual production of concentrated phosphate crop nutrients in Brazil and 100% of estimated annual potash production in Brazil.
Business Developments During 2024 In April 2024, we entered into an agreement with Saudi Arabian Mining Company ( Ma aden ) to exchange our 25% ownership of the Ma'aden Wa ad al Shamal Phosphate Company for 111,012,433 shares of Ma aden.
The transaction closed on December 24, 2024, at a value of approximately $1.5 billion, resulting in a pre-tax gain of approximately $0.5 billion.
The shares are reflected in Investments in Equity Securities in our Consolidated Balance Sheet at December 31, 2024.
In 2024, we repurchased 7,944,507 shares of Common Stock in the open market for approximately $235.4 million at an average purchase price of $29.63.
imposed tariff increases on imports from several countries, including a 25% tariff on most imports from Canada, including potash.